Patents by Inventor Cristina LeChiara
Cristina LeChiara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230301907Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: September 28, 2022Publication date: September 28, 2023Applicant: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Patent number: 11638692Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: GrantFiled: October 13, 2022Date of Patent: May 2, 2023Assignee: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20230102830Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: October 13, 2022Publication date: March 30, 2023Applicant: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20210169799Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: February 2, 2021Publication date: June 10, 2021Applicant: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Patent number: 10959946Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: GrantFiled: March 13, 2015Date of Patent: March 30, 2021Assignee: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Patent number: 10959949Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: GrantFiled: July 28, 2020Date of Patent: March 30, 2021Assignee: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Patent number: 10959947Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: GrantFiled: June 4, 2020Date of Patent: March 30, 2021Assignee: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Patent number: 10959948Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: GrantFiled: July 28, 2020Date of Patent: March 30, 2021Assignee: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20210038515Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: October 22, 2020Publication date: February 11, 2021Applicant: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20210023002Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: August 7, 2020Publication date: January 28, 2021Applicant: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20200360283Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: July 28, 2020Publication date: November 19, 2020Applicant: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20200352858Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: July 28, 2020Publication date: November 12, 2020Applicant: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20200306186Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: June 4, 2020Publication date: October 1, 2020Applicant: Azurity Pharmaceuticals, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Patent number: 10688046Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: GrantFiled: November 6, 2019Date of Patent: June 23, 2020Assignee: CutisPharma, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20200069584Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: November 6, 2019Publication date: March 5, 2020Applicant: CutisPharma, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Patent number: 10493028Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: GrantFiled: October 24, 2017Date of Patent: December 3, 2019Assignee: CutisPharma, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20180116955Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: October 24, 2017Publication date: May 3, 2018Applicant: CutisPharma, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Patent number: 9918903Abstract: A container suitable for the preparation, storage and dispensing of compounded suppositories is provided. Methods of preparing, storing and dispensing compounded suppositories utilizing such a container and related kits are also provided.Type: GrantFiled: January 26, 2016Date of Patent: March 20, 2018Assignee: CutisPharma, Inc.Inventors: Premal Gandhi, Cristina LeChiara
-
Publication number: 20170079910Abstract: The invention relates to stable vancomycin hydrochloride powder for oral liquid formulations. Also provided herein are methods of using vancomycin oral liquid formulations for the treatment of certain diseases such as Clostridium difficile pseudomembranous colitis and Staphylococcal enterocolitis as well as kits and related products thereof.Type: ApplicationFiled: March 13, 2015Publication date: March 23, 2017Applicant: CutisPharma, Inc.Inventors: Indu Muni, Peter Mione, Anisa Gandhi, Cristina LeChiara
-
Publication number: 20160213567Abstract: A container suitable for the preparation, storage and dispensing of compounded suppositories is provided. Methods of preparing, storing and dispensing compounded suppositories utilizing such a container and related kits are also provided.Type: ApplicationFiled: January 26, 2016Publication date: July 28, 2016Applicant: CutisPharma, Inc.Inventors: Premal Gandhi, Cristina LeChiara